I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Lenvatinib combined with anti-PD-1 antibodies plus transcat..:
Jun-Yi Wu
;
Jia-Yi Wu
;
Yi-Nan Li
...
https://www.frontiersin.org/articles/10.3389/fonc.2022.985380/full. , 2022
Link:
https://doi.org/10.3389/fonc.2022.985380
RT Journal T1 <Title>Lenvatinib combined with anti-PD-1 antibodies plus transcatheter arterial chemoembolization for neoadjuvant treatment of resectable hepatocellular carcinoma with high risk of recurrence: A multicenter retrospective study</Title> UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:942554f458e04ff4b3b3ee3e96f4f54b&Exemplar=1&LAN=DE A1 Jun-Yi Wu A1 Jia-Yi Wu A1 Yi-Nan Li A1 Fu-Nan Qiu A1 Song-Qiang Zhou A1 Zhen-Yu Yin A1 Yu-Feng Chen A1 Bin Li A1 Jian-Yin Zhou A1 Mao-Lin Yan PB Frontiers Media S.A. YR 2022 K1 hepatocellular carcinoma K1 neoadjuvant treatment K1 triple therapy K1 disease-free survival (DFS) K1 overall survival (OS) K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://www.frontiersin.org/articles/10.3389/fonc.2022.985380/full LK http://dx.doi.org/https://doi.org/10.3389/fonc.2022.985380 DO https://doi.org/10.3389/fonc.2022.985380 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)
